Valuation: Measuring and Managing the Value of Companies
ISBN: 1119610885
EAN13: 9781119610885
Language: English
Pages: 896
Dimensions: 2.00" H x 10.00" L x 7.00" W
Weight: 3.00 lbs.
Format: Hardcover
Publisher:

Valuation: Measuring and Managing the Value of Companies

Select Format Format: Hardcover Select Conditions Condition: Very Good

Selected

Format: Hardcover

Condition: Very Good

$27.21
Quantity
1 Available

Select Conditions
  • Very Good $27.21 Valuation: Measuring and Managing the Value of Companies
  • New $95 Valuation: Measuring and Managing the Value of Companies
Book Overview
McKinsey & Company's #1 best-selling guide to corporate valuation--the fully updated seventh edition Valuation has been the foremost resource for measuring company value for nearly three decades. Now in its seventh edition, this acclaimed volume continues to help financial professionals around the world gain a deep understanding of valuation and help their companies create, manage, and maximize economic value for their shareholders. This latest edition has been carefully revised and updated throughout, and includes new insights on topics such as digital, ESG (environmental, social and governance), and long-term investing, as well as fresh case studies. Clear, accessible chapters cover the fundamental principles of value creation, analyzing and forecasting performance, capital structure and dividends, valuing high-growth companies, and much more. The Financial Times calls the book one of the practitioners' best guides to valuation. This book: Provides complete, detailed guidance on every crucial aspect of corporate valuation Explains the strategies, techniques, and nuances of valuation every manager needs to know Covers both core and advanced valuation techniques and management strategies Features/Includes a companion website that covers key issues in valuation, including videos, discussions of trending topics, and real-world valuation examples from the capital markets For over 90 years, McKinsey & Company has helped corporations and organizations make substantial and lasting improvements in their performance. Through seven editions and 30 years, Valuation: Measuring and Managing the Value of Companies, has served as the definitive reference for finance professionals, including investment bankers, financial analysts, CFOs and corporate managers, venture capitalists, and students and instructors in all areas of finance.
Editor Reviews
From the Back Cover McKinsey & Company's #1 bestselling guide to corporate valuation, now in its Seventh Edition The revised Seventh Edition of Valuation offers detailed, step-by-step explanations of how to easily and effectively measure and manage the value of companies. This book contains proven valuation frameworks that have been used successfully in McKinsey & Company's consulting work, including illustrative case studies that put the spotlight on practical judgments involved in developing and using valuations. PRAISE FOR VALUATION The book's clarity and comprehensive coverage make it one of the best practitioners' guides to valuation. --Financial Times Valuation . . . is a reminder of why shareholder value is still the most powerful idea in business and why many criticisms thrown at it are unfair. --The Economist A 'how to' guide for corporate executives who want to get at the unrealized shareholder values trapped in public companies. --The New York Times Cuts through the clutter and confusion to focus executives on what really drives value creation. --Fernando Tennenbaum, CFO, AB InBev Clearly articulates both the principles and practical applications of creating value. --John Graham, D. Richard Mead Professor of Finance, Fuqua School of Business, Duke University The best valuation book just got better. It is required reading for all executives. --Benjamin C. Esty, Roy and Elizabeth Simmons Professor of Business Administration, Harvard Business School The bible in its field. Anyone wanting to understand what drives corporate value should read this latest edition. --Dr. Raymond Breu, retired CFO, Novartis AG